Matches in Wikidata for { <http://www.wikidata.org/entity/Q66397250> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q66397250 description "clinical trial" @default.
- Q66397250 description "ensayu clínicu" @default.
- Q66397250 description "klinisch onderzoek" @default.
- Q66397250 description "клінічне випробування" @default.
- Q66397250 name "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 name "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 type Item @default.
- Q66397250 label "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 label "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 prefLabel "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 prefLabel "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 P1132 Q66397250-3529D904-48C4-4A0B-97DD-90509D2FE93A @default.
- Q66397250 P1476 Q66397250-38F381C8-3757-4E17-88E7-15AD2E4E9252 @default.
- Q66397250 P17 Q66397250-05445B90-383E-44F9-AA61-09CE241B45D6 @default.
- Q66397250 P17 Q66397250-3EBEEDFF-2AC5-4A7F-B46B-6FB696B8D836 @default.
- Q66397250 P17 Q66397250-469867A4-B46A-4514-91B1-627793F3D155 @default.
- Q66397250 P17 Q66397250-5BBDB378-DE68-49F1-8A8B-675DA9F7728D @default.
- Q66397250 P17 Q66397250-73A8A5FD-B16A-4830-B8A8-85335BBF6B6C @default.
- Q66397250 P17 Q66397250-8E7BA081-53D6-4545-845B-34CF7EA35CFD @default.
- Q66397250 P17 Q66397250-99765F6F-444F-459C-AAF3-CF162FF27101 @default.
- Q66397250 P17 Q66397250-9D4C8AE4-D1B6-492A-B323-638717187CDD @default.
- Q66397250 P17 Q66397250-AB7F73A9-5A33-49BA-9558-EA066B85984B @default.
- Q66397250 P17 Q66397250-BAC8583E-9D3D-4CC1-A26A-52317B3283F9 @default.
- Q66397250 P17 Q66397250-D334AFA1-3274-45E0-8E11-DF9E2DE79AFF @default.
- Q66397250 P2899 Q66397250-89CDDA8F-AFA6-4E0D-8250-497DCE0299BD @default.
- Q66397250 P3098 Q66397250-2A43DC2D-44B9-49A2-A4D9-7C8B6702CCCA @default.
- Q66397250 P31 Q66397250-2D8F87B3-CA89-4024-B6AB-11CCC51C1C44 @default.
- Q66397250 P580 Q66397250-BAB39491-62D3-4F45-B53B-E3BCFCF30B7F @default.
- Q66397250 P582 Q66397250-2227AAF6-D56E-47A3-AE81-446F2AB629B4 @default.
- Q66397250 P8363 Q66397250-7962FC12-D699-46FD-B0E8-8E25E54D0A32 @default.
- Q66397250 P859 Q66397250-32590A33-4DD8-4F4D-86A5-43E7333F5BAB @default.
- Q66397250 P1132 "+1200" @default.
- Q66397250 P1476 "Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice" @default.
- Q66397250 P17 Q1183 @default.
- Q66397250 P17 Q142 @default.
- Q66397250 P17 Q145 @default.
- Q66397250 P17 Q183 @default.
- Q66397250 P17 Q29 @default.
- Q66397250 P17 Q30 @default.
- Q66397250 P17 Q31 @default.
- Q66397250 P17 Q38 @default.
- Q66397250 P17 Q39 @default.
- Q66397250 P17 Q40 @default.
- Q66397250 P17 Q408 @default.
- Q66397250 P2899 "+18" @default.
- Q66397250 P3098 "NCT02847728" @default.
- Q66397250 P31 Q30612 @default.
- Q66397250 P580 "2016-07-31T00:00:00Z" @default.
- Q66397250 P582 "2024-03-31T00:00:00Z" @default.
- Q66397250 P8363 Q818574 @default.
- Q66397250 P859 Q266423 @default.